These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12022082)

  • 21. [Safety and tolerability of gabapentin].
    Viteri C
    Rev Neurol; 2002 Feb 1-15; 34(3):292-5. PubMed ID: 12022084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
    Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T
    Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
    Mattia D; Spanedda F; Bassetti MA; Romigi A; Placidi F; Marciani MG
    Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of gabapentin-lactam in serum of patients under gabapentin therapy.
    Knörle R; Feuerstein TJ; Schulze-Bonhage A
    Arzneimittelforschung; 2004; 54(3):139-42. PubMed ID: 15112859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gabapentin in children and adolescents with epilepsy].
    Herranz JL
    Rev Neurol; 2002 Feb 16-28; 34(4):384-7. PubMed ID: 12022057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy.
    Gidal BE; DeCerce J; Bockbrader HN; Gonzalez J; Kruger S; Pitterle ME; Rutecki P; Ramsay RE
    Epilepsy Res; 1998 Jul; 31(2):91-9. PubMed ID: 9714500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myoclonus associated with the use of gabapentin.
    Asconapé J; Diedrich A; DellaBadia J
    Epilepsia; 2000 Apr; 41(4):479-81. PubMed ID: 10756416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential cognitive effects of carbamazepine and gabapentin.
    Meador KJ; Loring DW; Ray PG; Murro AM; King DW; Nichols ME; Deer EM; Goff WT
    Epilepsia; 1999 Sep; 40(9):1279-85. PubMed ID: 10487192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monotherapy using gabapentin in epilepsy].
    Sancho-Rieger J; López-Trigo J
    Rev Neurol; 2002 Feb 1-15; 34(3):290-2. PubMed ID: 12022083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
    Herranz JL; Sol JM; Hernández G
    Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A; Chandra D; Puri V; Mallika V
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gabapentin: a unique anti-epileptic agent.
    Dougherty JA; Rhoney DH
    Neurol Res; 2001 Dec; 23(8):821-9. PubMed ID: 11760873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of age and gender on single-dose pharmacokinetics of gabapentin.
    Boyd RA; Türck D; Abel RB; Sedman AJ; Bockbrader HN
    Epilepsia; 1999 Apr; 40(4):474-9. PubMed ID: 10219274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients.
    Huber B; Tomka-Hoffmeister M
    Seizure; 2003 Dec; 12(8):602-3. PubMed ID: 14630502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers.
    Noachtar S; von Maydell B; Fuhry L; Büttner U
    Epilepsy Res; 1998 Jun; 31(1):47-57. PubMed ID: 9696300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
    Muscas GC; Chiroli S; Luceri F; Mastio MD; Balestrieri F; Arnetoli G
    Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gabapentin, an antiepileptic drug, improves memory storage in mice.
    Acosta GB; Boccia MM; Baratti CM
    Neurosci Lett; 2000 Feb; 279(3):173-6. PubMed ID: 10688057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.